Treatment of an Acquired Coagulopathy with Recombinant Activated Factor VII in a Damage-Control Patient

Abstract

Recombinant activated factor VII is commonly used for the treatment of hemophiliac patients with inhibitors and has been studied for the use in trauma. We report the use of recombinant activated factor VII for a male patient who was injured in a motor vehicle accident. We also summarize the animal studies and clinical trials that have been reported.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 01, 2005
Accession Number
ADA628129

Entities

People

  • Frederick A. Moore
  • John B Holcomb
  • Keith Hoots

Organizations

  • United States Army Institute of Surgical Research

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Accidents
  • Blood Coagulation Factors
  • Clinical Trials
  • Copyrights
  • Information Operations
  • Military Medicine
  • Motor Vehicle Accidents
  • Motor Vehicles
  • United States

Fields of Study

  • Medicine

Readers

  • Trauma Surgery or Emergency Medicine.